长期护理所有权和运营商因素可能 Delirium:一个基于人口的研究从安大略省,加拿大
Rhiannon Roberts1, Peter Tanuseputro2, Peter Lawlor3
1Ottawa Hospital Research Institute, Ottawa, Ontario, Canada.
概括
在较大设施 (≥50张床位) 的长期护理住院居民的可能 Delirium 的几率较低. 痴呆症的患病率并没有因所有权模式,运营商规模或链条地位而有显著差异.
科学领域:
- 老年学是一门学科.
- 医疗保健管理的管理
- 公共卫生 公共卫生
背景情况:
- 狂妄症是长期护理 (LTC) 居民中常见且严重的疾病.
- 了解与妄想患病率相关的因素对于改善住院护理至关重要.
- 在LTC的房屋所有权模式和运营商的特点可能会影响护理质量和居民的结果.
研究的目的:
- 调查LTC房屋所有权模型和运营商特征与可能妄想的流行之间的关联.
- 在LTC设置中识别可能减少妄想风险的潜在可修改因素.
主要方法:
- 使用加拿大安大略省省级卫生行政数据进行的横截面研究.
- 包括2016-2019年期间评估的65-105岁的169,762名LTC居民.
- 使用居民评估仪器-最小数据集 (RAI-MDS 2.0) 和后勤回归分析确定了可能的妄想.
主要成果:
- 在研究人群中,可能妄想的患病率为3.6%.
- 居住在较大的LTC住宅 (≥50张床位) 的居民显示,可能 Delirium 的几率降低.
- 在营利性,非营利性或市政所有权模式之间,以及经营者规模或链条地位之间,没有发现可能的妄想患病率的显著差异.
结论:
- 较大的LTC设施与较低的可能妄想的患病率有关.
- 研究结果表明,在各种设施大小之间, Delirium 风险或检测机制可能存在差异.
- 目前的所有权模式和运营商特征似乎没有影响LTC. Delirium的流行率.
更多相关视频
07:42Dual-Task Stroop Paradigm for Detecting Cognitive Deficits in High-Functioning Stroke Patients
Published on: December 16, 2022
2.8K
04:13Using a Real-Time Locating System to Measure Walking Activity Associated with Wandering Behaviors Among Institutionalized Older Adults
Published on: February 8, 2019
6.7K
相关概念视频
Dementia
74
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
74
Documentation in Long-Term and Home Healthcare Setting
835
Documentation in long-term care facilities and home healthcare settings is crucial for ensuring continuous, coordinated, and comprehensive care for patients. Each setting has its specific documentation processes and tools:
Long-Term Care Facilities
Long-Term Care Facilities
835
Continuing Care
1.4K
Continuing care describes the variety of health, personal, and social services provided over a prolonged period. The need for continuing care is increasing because people are living longer. Many people do not have families or others to care for them. Continuing care is mainly for patients who are disabled, functionally dependent, or suffering from a terminal disease. It is available within institutional settings or in homes. Examples include nursing centers or facilities, assisted living,...
1.4K
Long-term Depression
2.5K
Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
Calcium Ion Concentration Mechanism
If over...
Calcium Ion Concentration Mechanism
If over...
2.5K
Alzheimer's Disease: Overview
342
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
342
Alzheimer's Disease: Treatment
133
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
133
